Is it possible that Poonawalla has his eyes on buying out NVAX at this low valuation and will wait for, or help drive the price lower for an easier, cheaper acquisition? 🤔. We know that NVAX has always claimed “leveraging” SII, but the tables have turned and SII can now leverage NVAX into the ground. Are they a trusted partner? Anything in their contract that prevents a hostile take-under?

EDIT: Makes me wonder how it’s even possible that India hasn’t fully approved the NVAX vaccine. Another strange thing is that SII hasn’t pushed for a malaria vaccine strain for use in India immediately and will need another 2 years or so to get it to market. One of the main things that scares me when visiting India are the mosquitos 🦟